Form 4: QuidelOrtho Director Reports Stock Unit Vesting

QuidelOrtho Corp director Kenneth J. Widder reported the vesting of restricted stock units, converting them into common stock.

Summary

• Kenneth J. Widder, a Director at QuidelOrtho Corp (QDEL), has reported the vesting of restricted stock units (RSUs) on June 6, 2026.
• A total of 910 RSUs were released and converted into 910 shares of common stock.
• Additionally, 273 "Premium" RSUs were released, also converting into common stock.
• These transactions were part of a deferred compensation program for non-employee directors and followed an elected deferred schedule.
• The reported transactions do not involve any monetary cost to Mr. Widder as they represent the release of previously awarded equity.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents the normal vesting of previously awarded compensation rather than a new strategic event or significant change in beneficial ownership.

Positives

• Vesting of restricted stock units indicates the fulfillment of equity awards granted to the director.
• The conversion of RSUs into common stock increases the director's direct beneficial ownership of the company's equity.

Negatives

• No direct financial negatives are apparent from this type of transaction, as it represents the culmination of prior compensation awards.

Risks

• The filing does not explicitly mention any risks associated with these transactions.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Management Comments

• The release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing details the conversion of deferred compensation into actual shares, a common practice in executive compensation.

Comparison to Industry Standards

• The reporting of restricted stock unit vesting by a director is a standard practice across the biotechnology and diagnostics industry, aligning with common executive compensation structures.

Stakeholder Impact

• Shareholders gain transparency into the director's direct equity holdings.
• The director's personal financial stake in the company is directly represented by the increased number of common shares held.

Next Steps

• The director's beneficial ownership of QuidelOrtho common stock has been updated to reflect the vested shares.

Key Dates

Keywords

QuidelOrtho Corp, QDEL, Form 4, Insider Trading, Director Compensation, Restricted Stock Units, Equity Vesting, Beneficial Ownership, Securities Exchange Act